Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Strand Therapeutics Appoints Kunal Bhatia as Chief Financial Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Strand Therapeutics Appoints Kunal Bhatia as Chief Financial Officer

Bhatia brings 15 years of investment banking experience.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Kunal Bhatia.

Strand Therapeutics, a clinical-stage biotechnology company pioneering programmable mRNA medicines, has appointed Kunal Bhatia as Chief Financial Officer (CFO).

Bhatia brings 15 years of investment banking experience, driving fundraising, business development, and M&A for over 100 public and private biopharmaceutical companies.

“With early validation of our platform in the clinic, we have built a pipeline from solid tumor immuno-oncology to systemic delivery to in vivo cell therapy. As we enter the next chapter, we’ve identified a financial leader who matches Strand’s ambition and momentum,” said Jake Becraft, PhD, Co-founder and CEO of Strand Therapeutics. “Having worked alongside some of the most ambitious biotech builders through capital raises and transactions, Kunal knows what it takes to scale innovative platform companies through their critical growth stages.”

Experience

Prior to joining Strand, Bhatia served as interim Chief Financial Officer and Chief Business Officer to a portfolio of private life sciences companies. Previously, he was a Managing Director in the Healthcare Investment Banking Group at Cowen, where he was integral to the growth of the firm’s life sciences franchise, and before that, held investment banking roles at Jefferies and Credit Suisse.

“Strand is at an inflection point, with clinical momentum, a growing pipeline, and the kind of investor syndicate that reflects real conviction in the platform,” said Bhatia. “I’m looking forward to working with the team to build on that foundation as the company enters its next phase.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics